A Review Of Myositis rehabilitation center
Rituximab is a chimeric monoclonal antibody from the CD20 antigen expressed to the floor of B lymphocytes leading to their depletion within the peripheral blood. quite a few case studies, case collection and open up-label trials have prompt a helpful influence of rituximab in clients with refractory myositis (the latest overview in exploration by F